title: IgG western blot for confirmatory diagnosis of equivocal cases of toxoplasmosis by EIA-IgG and fluorescent antibody test.
abstract: The performance values of available techniques used in serodiagnosis of toxoplasmosis are satisfactory but they raise problems of equivocal and discordant results for very low IgG titers. Recently marketed, LDBio-Toxo II IgG Western blot (IB) showed an excellent correlation with the dye test. We estimated the proportion of equivocal and discordant results between the enzyme immunoassay Platelia Toxo IgG (EIA-IgG) and fluorescent antibody test (FAT) and assessed the usefulness of the IB as a confirmatory test. Out of 2,136 sera collected from pregnant women, 1,644 (77.0%) tested unequivocally positive and 407 (19.0%) were negative in both EIA-IgG and FAT. The remaining 85 (4%) sera showed equivocal or discordant results. Among them, 73 (85.9%) were positive and 12 (14.1%) were negative in IB. Forty-one (89.1%) equivocal sera in EIA-IgG and 46 (86.8%) equivocal sera in FAT were positive in IB. Reducing the cut-off values of both screening techniques improved significantly their sensitivity in detecting very low IgG titers at the expense of their specificity. In conclusion, equivocal results in routine-used techniques and their discordance in determination of the immune status in pregnancy women were not uncommon. IB test appeard to be highly useful in these situations as a confirmatory technique.
authors.affiliation: UR 12 SP 34 Research Unit, Ministry of Public Health, Tunis, Tunisia.
authors.forename: Imen
authors.initials: I
authors.lastname: Khammari
authors.forename: Fatma
authors.initials: F
authors.lastname: Saghrouni
authors.forename: Alia
authors.initials: A
authors.lastname: Yaacoub
authors.forename: Sondoss
authors.initials: S
authors.lastname: Gaied Meksi
authors.forename: Hinda
authors.initials: H
authors.lastname: Ach
authors.forename: Lamia
authors.initials: L
authors.lastname: Garma
authors.forename: Akila
authors.initials: A
authors.lastname: Fathallah
authors.forename: Moncef
authors.initials: M
authors.lastname: Ben Saïd
mesh_terms: D000328:Adult; D000913:Antibodies, Protozoan / Q000032:analysis* / Q000097:blood; D015153:Blotting, Western / Q000379:methods*; D005260:Female; D005455:Fluorescent Antibody Technique / Q000379:methods*; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D007075:Immunoglobulin M / Q000032:analysis* / Q000097:blood; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000097:blood / Q000175:diagnosis*; D014123:Toxoplasmosis / Q000097:blood / Q000175:diagnosis*; D055815:Young Adult
chemical_list: D000913:Antibodies, Protozoan; D007075:Immunoglobulin M
keywords: Toxoplasma gondii; immunoblot; pregnant women; serodiagnosis; toxoplasmosis
references.citation: Diagn Microbiol Infect Dis. 2010 Dec;68(4):352-7
references.pmid: 20884150
references.citation: Diagn Microbiol Infect Dis. 1998 Sep;32(1):65-7
references.pmid: 9791760
references.citation: Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1207-12
references.pmid: 21484254
references.citation: Clin Vaccine Immunol. 2011 Nov;18(11):1908-12
references.pmid: 21880851
references.citation: J Infect. 2001 Jan;42(1):16-9
references.pmid: 11243748
references.citation: Br J Biomed Sci. 2003;60(2):105-8
references.pmid: 12866920
references.citation: J Clin Microbiol. 1997 Dec;35(12):3313-5
references.pmid: 9399544
references.citation: Bull World Health Organ. 1999;77(11):929-35
references.pmid: 10612889
references.citation: Clin Microbiol Rev. 2012 Apr;25(2):264-96
references.pmid: 22491772
references.citation: J Clin Microbiol. 2008 Jul;46(7):2334-8
references.pmid: 18480220
references.citation: Clin Infect Dis. 2008 Aug 15;47(4):554-66
references.pmid: 18624630
references.citation: J Clin Pathol. 1960 Jul;13:339-48
references.pmid: 14412642
references.citation: Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):359-63
references.pmid: 20151168
references.citation: Parassitologia. 2008 Jun;50(1-2):51-3
references.pmid: 18693557